• $8.0M
    Market Cap
  • -41.00%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 9
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Tenon Medical (TNON) Q4 2025 Earnings Transcript

Tenon Medical reported Q4 2025 revenue of $1.5 million, up 92% year-over-year, with full-year revenue of $3.9 million representing 20% growth. The company achieved record gross margins of 69% in Q4 (up from 46%) driven by operational efficiencies. Key milestones include FDA 510(k) clearance for the SImmetry+ SI-Joint Fusion System and successful initial clinical cases. The company closed a $4.3 million senior convertible note financing post-quarter end and ended the period with $3.8 million in cash and zero debt. Management highlighted strong physician adoption momentum and multiple product launches planned for 2026.

03/19/2026, 7:18 PM • The Motley Fool

Peers

Statistics

More
Day Range
$0.58
$0.68
$0.63
1-Year Range
$0.63
$1.67
$0.63
Latest Close$0.63
Change
-$0.05 (-7.36%)
Volume204,348
Market Cap$8.0M
Shares Outstanding11.6M
P/E (TTM)-0.0007
Diluted EPS (TTM)-$963.26
Enterprise Value$6.9M

Information as of 06/02/2026

Company Profile

TENON MEDICAL INC
https://www.tenonmed.com
$8.0M
Market Cap
-$8.9M
Net Income
Sector: Healthcare
Industry: Medical Devices
104 Cooper Court, Los Gatos, CA, United States, 95032
408 649 5760

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Key Executives

  • Steven Foster
  • Kevin Williamson
  • Richard Ginn
  • Steve Moscaret
  • Richard Ferrari

Current Ownership Distribution

  • Institutions14.1M (74.79%)
  • Mutual Funds3.6M (19.18%)
  • Insiders1.1M (6.03%)
  • Other0 (0.00%)